Why the study?
Do microalbuminuria and obesity independently or additively increase the risk of cardiovascular disease and mortality in the general population?
Do microalbuminuria and obesity independently or additively increase the risk of cardiovascular disease and mortality in the general population?
Microalbuminuria and obesity have additive, independent effects on mortality risk, suggesting that microalbuminuria screening should be incorporated into routine health examinations alongside obesity measurements.
No takes yet. Share an insight, caveat, or question.
May refine mortality risk stratification in cohorts; leaves open independent CVD prediction and screening utility.
Klausen et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: